Hypoxia alters cathepsin B / inhibitor profiles in oral carcinoma cell lines

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2841-2850

  Wickramasinghe, Nalinie S ^a,c   Banerjee, Kasturi ^a,d   Nagaraj, Nagathihalli S ^a   Vigneswaran, Nadarajah ^b   Zacharias, Wolfgang ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Cathepsin; Cystatin; Hypoxia; Oral carcinoma

Indexed keywords

CATHEPSIN B; CYSTATIN B; CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HIF 1ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LYMPH NODE METASTASIS; MALE; MICROENVIRONMENT; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH;

AGED; CARCINOMA, SQUAMOUS CELL; CATHEPSIN B; CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE, TUMOR; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS;

EID: 22944444536     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Witz IP: The tumor microenvironment - introduction. Sem Cancer Biol 12: 87-88, 2002.
2. Subarsky P and Hill RP: The hypoxic tumor microenvironmental and metastatic progression. Clin Exp Metast 20: 237-250, 2003.
3. Wykoff CC, Beasley NJP, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talk KL, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris A: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075-7083, 2000.
4. Le Q-T, Denko NC and Giaccia AJ: Hypoxic gene expression and metastasis. Cancer Metast Rev 23: 293-310, 2004.
5. Michiels C: Physiological and pathological responses to hypoxia. Am J Pathol 164: 1875-1882, 2004.
6. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P and Semenza GL: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63: 1138-1143, 2003.
7. Burke B, Giannnousdis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L and Lewis CE: Hypoxia-induced gene expression in human macrophages. Implication for ischemic tissue hypoxia regulated gene therapy. Am J Pathol 163: 1233-1243, 2003.
8. Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter KC and Harris AL: Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Physics 59: 67-71, 2004.
9. Mohamed KM, Le A, Duong H, Wu Y, Zhang Q and Messadi DV: Correlation between VEGF and HIF-1α expression in human oral squamous cell carcinoma. Exp Mol Pathol 76: 143-152, 2004.
10. Huang E and Bunn HF: Hypoxia-inducible factor and biomedical revelance. J Biol Chem 278: 19575-19578, 2003.
11. Nagaraj NS, Vigneswaran N and Zacharias W: Hypoxia-mediated apoptosis in oral carcinoma cells occurs via two independent pathways. BMC Mol Cancer 3: 38, 2004.
12. Agarwal SK: Cathepsins - a view. Biochem Edu 18: 67-72, 1990.
13. Turk B, Turk D and Turk V: Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 1477: 98-111, 2000.
14. Roshy S, Sloane BF and Moin K: Pericellular cathepsin B and malignant progression. Cancer Metast Rev 22: 271-286, 2003.
15. Coulibaly S, Schwihla H, Abramhamson M, Albini A, Cerni C, Clark JS, Ng KN, Katunuma N, Schlappack O, Glossl J and Mach L: Modulation of invasion properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 83: 526-531, 1999.
16. Vigneswaran N, Zhao W, Dasanayake A, Muller S, Miller DM and Zacharias W: Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Human Pathol 31: 931-937, 2000.
17. Turk V and Bode W: Human cysteine proteinases and their inhibitors, stefins and cystatins. In: Innovations in Proteases and their Inhibitors (Avile FX, ed), Berlin: Walter de Gruyter, pp. 47-59, 1993.
18. Zajc I, Sever N, Bervar A and Lah TT: Expression of cysteine peptidase cathepsin L and its inhibitors stefin A and B in relation to tumorigenicity of breast cancer cell lines. Cancer Lett 18: 185-190, 2002.
19. Kos J and Lah TT: Cysteine proteinases and their endogenous inhibitor: target protein for prognosis, diagnosis and therapy in cancer. Oncol Rep 5: 1349-1361, 1998.
20. Vigneswaran N, Wu J and Zacharias W: Upregulation of cystatin M during the progression of oral squamous cell carcinoma from primary tumor to metastasis. Oral Oncol 39: 559-568, 2003.
21. Sacks PG: Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metast Rev 15: 27-51, 1996.
22. Troen BR, Ascherman D, Atlas D and Gottesman MM: Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. J Biol Chem 263: 254-261, 1988.
23. Ulbricht B, Spiess E, Albiez RS and Ebert W: Quantification of intracellular cathepsin activities in human lung tumor cell lines by flow cytometry. Biol Chem Hoppe-Seyler 376: 407-414, 1995.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
25. Barrett AJ and Krischke H: Cathepsin B, cathepsin H and cathepsin L. In: Methods in Enzymology Vol. 80. (Lorand L, ed.) New York, Academic Press, pp. 535-561, 1981.
26. Sen CL and Whitaker JR: Some properties of ficin-papain inhibitor from avian egg white. Arch Biochem Biophys 158: 623-632, 1973.
27. Webster L, Hodgkiss RJ and Wilson GD: Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo. Br J Cancer 77: 227-234, 1998.
28. Jensen PO, Mortensen BT, Hodgkiss RJ, Iversen PO, Christensen IJ, Helledie N and Larsen JK: Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats. Cell Prolif 33: 381-395, 2000.
29. Schmaltz C, Hardenbergh PH, Wells A and Fisher DE: Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 18: 2845-2854, 1998.
30. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
31. Greijer AE and van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57: 1009-1014, 2004.
32. Zhong H, De Marzo MD, Laugher E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW: Overexpression of hypoxia-inducible factor 1 α in common human cancers and their metastasis. Cancer Res 59: 5830-5835, 1999.
33. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL: The expression and distribution of hypoxia-inducible factor HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157: 411-421, 2000.
34. Jiang BH, Semenza GL, Bauer C and Martin HH: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of oxygen tension. Am J Physiol 271: 1172-1180, 1996.
35. Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Lakka SS, Kin Y, Fuller GN, Yung AWK, Kyritsis AP, Dinh DH, Oliver WC, Gujrati M, Ali-Osman F and Rao J: Down regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 20: 3665-3673, 2001.
36. Cuvier C, Jang A and Hill RP: Exposure to hypoxia, glucoses starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L+B) secretion. Clin Exp Metast 15: 19-25, 1997.
37. Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J and Skrk J: Prognostic significance of cysteine proteinases cathepsin B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 6: 1052-1062, 2000.
38. Kawasaki G, Kato Y and Mizuno A: Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93: 446-454, 2002.
39. Yan S, Sameni M and Sloane BF: Cathepsin B and human tumor progression. Biol Chem 379: 113-23, 1988.
40. Sexton PS and Cox JL: Inhibition of motility and invasion of B16 melanomas by over-expression of cystatin C. Melanoma Res 7: 97-101, 1997.
41. Saleh Y, Ziolkowski P, Siewinski M, Milach J, Marszalik P and Rybka J: The combined treatment of transplantable solid mammary carcinoma in Wistar rats by use of photodynamic therapy and cysteine proteinase inhibitor. In Vivo 15: 351-357, 2001.
42. Siewinski M, Saleh Y, Popiela A, Ziolkowski P, Jelen M and Grybos M: Expression of high molecular weight cysteine proteinase inhibitor in ovarian cancer tissues: regulation of cathepsin B expression by placental CPI. Biol Chem 384: 1103-1107, 2003.
43. Lee J-W, Bae S-H, Jeong J-W, Kim S-H and Kim K-W: Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions. Exp Molec Med 36: 1-12, 2004.
44. Koblinski JE, Ahram M and Sloane BF: Unraveling the role of proteases in cancer. Clin Chim Acta 291: 113-135, 2000.